VFPI
ABBV icon

Vantage Financial Partners (Illinois)’s AbbVie ABBV Stock Holding History

Vantage Financial Partners (Illinois)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,244
Closed -$227K – 104
2024
Q1 		$227K Buy
+1,244
New +$214K 0.06% 101
2023
Q4 		– Sell
-1,369
Closed -$204K – 103
2023
Q3 		$204K Buy
+1,369
New +$201K 0.12% 87
2023
Q2 		– Sell
-1,405
Closed -$224K – 93
2023
Q1 		$224K Sell
1,405
-25
-2% -$3.82K 0.13% 89
2022
Q4 		$231K Sell
1,430
-335
-19% -$51.4K 0.13% 89
2022
Q3 		$237K Hold
1,765
– – 0.15% 79
2022
Q2 		$270K Buy
1,765
+415
+31% +$63.4K 0.16% 78
2022
Q1 		$219K Sell
1,350
-8,150
-86% -$1.18M 0.11% 79
2021
Q4 		$1.29M Hold
9,500
– – 0.65% 30
2021
Q3 		$1.02M Buy
9,500
+700
+8% +$80K 0.55% 36
2021
Q2 		$991K Buy
8,800
+800
+10% +$90.1K 0.55% 36
2021
Q1 		$866K Hold
8,000
– – 0.49% 36
2020
Q4 		$857K Buy
8,000
+350
+5% +$33.6K 0.5% 37
2020
Q3 		$670K Buy
7,650
+100
+1% +$9.41K 0.41% 44
2020
Q2 		$741K Buy
7,550
+1,100
+17% +$96.8K 0.47% 34
2020
Q1 		$491K Buy
6,450
+450
+8% +$38.3K 0.35% 40
2019
Q4 		$531K Buy
6,000
+1,500
+33% +$125K 0.31% 45
2019
Q3 		$341K Buy
+4,500
New +$309K 0.23% 54
2018
Q1 		– Sell
-4,000
Closed -$387K – 76
2017
Q4 		$387K Hold
4,000
– – 0.26% 52
2017
Q3 		$356K Sell
4,000
-4,880
-55% -$371K 0.25% 50
2017
Q2 		$645K Hold
8,880
– – 0.46% 31
2017
Q1 		$580K Buy
8,880
+1,000
+13% +$62.9K 0.41% 30
2016
Q4 		$494K Buy
+7,880
New +$481K 0.44% 21

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Vantage Financial Partners (Illinois)'s ABBV Position: Q2 2024 in Review

Vantage Financial Partners (Illinois) sold out of AbbVie (ABBV) in Q2 2024, closing a stake of 1,244 shares — an estimated $227K sold.

Vantage Financial Partners (Illinois) first reported a position in ABBV in Q4 2016 and held it in 22 quarters. The position peaked at $1.29M in Q4 2021. 3,365 funds tracked by Wall St. Rank hold ABBV as of Q2 2024.

  • Vantage Financial Partners (Illinois) reported no remaining AbbVie position as of Q2 2024 after selling out during the quarter.
  • Vantage Financial Partners (Illinois) sold 1,244 AbbVie shares in Q2 2024, an estimated $227K.
  • Vantage Financial Partners (Illinois) first reported a position in AbbVie in Q4 2016 and held it in 22 quarters.
  • Vantage Financial Partners (Illinois)'s AbbVie position peaked at $1.29M in Q4 2021.
  • 3,365 funds tracked by Wall St. Rank held AbbVie as of Q2 2024.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2024, filed 14 Aug 2024.